Glenmark life sciences IPO allotment status check online: Shortest way! Check directly from BSE, Kfintech - Know refund, listing dates and more

As per Upstox, Glenmark Life Sciences allotment status will be made available on or around August 3, 2021. The allotted shares will be credited to the account by August 5, 2021. The refund initiation will begin on August 4, 2021, while listing on exchanges will be done on August 6, 2021.  Source: PTI

Step 1: Visit the link: bseindia.com/investors/appli_check.aspx on your browser and visit BSE official website.    

Step 2: Select 'Equity' for issue type in the dropdown menu    

Step 3: Next, select the name of the IPO, which is Glenmark Life Sciences Limited IPO   

Step 4: Now, enter application number & PAN number     

Step 5: Hit search button and you are good to go. You can see your IPO allotment on the screen    

Pic Source: Pixabay

Step 1: Visit Glenmark Life Sciences Limited IPO registrar link: https://kosmic.kfintech.com/ipostatus/ 

Step 2: Now, select IPO Name- Glenmark Life Sciences Limited IPO    

Step 3:  Select the option through which you would want to check allotment status in 'Query By', which is Application No/DPID/Client ID/PAN   

Step 4: Select Application type, which is ABSA or Non-ABSA  

Step 5: Enter Application No (In case you have chosen to check via Application No) and Captcha   

Step 6: Once all relevant field are completed, hit submit to check your IPO Allotment status. 

Source: PTI

Glenmark Life Sciences Limited IPO comprises fresh issue of equity shares worth Rs 1,060 crore and an offer for sale by existing shareholders worth Rs 453 crore, totaling Rs 1513.60 crore. Glenmark Life Sciences Limited IPO price band is Rs 695 to Rs 720 per equity share and IPO lot size comprises 20 equity shares and in multiples of 20 equity shares thereof.  Minimum investment required for Glenmark Life Sciences Limited IPO is Rs 13,900, while maximum purchase limit on UPI is Rs 2 lakh per transaction, as per the company DRHP (Detailed Red Herring Prospectus). Source: PTI

Glenmark Life Sciences Ltd is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (“APIs”) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management and diabetes. The Company also manufactures and sells APIs for gastro-intestinal disorders, anti-infectives and other therapeutic areas. Source: Pixabay